Mechanisms for systemic inflammation in COPD
COPD 全身炎症的机制
基本信息
- 批准号:24659405
- 负责人:
- 金额:$ 2.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Challenging Exploratory Research
- 财政年份:2012
- 资助国家:日本
- 起止时间:2012-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We collected visceral fat tissues (n=120) during abdominal surgery for mainly early abdominal malignancies and investigated inflammatory cells including macrophages and cytokines. The COPD group having obstructive ventilatory impairment and smoking history did not have significantly increased number of macrophages which is a marker for fat tissue inflammation, when compared to non-smokers or healthy smokers. Further, in the COPD group with high serum CRP tended to have higher visceral fat macrophages than those with low CRP, but did not reach to be significant. In the entire study, both BMI and %VC were significantly correlated with the number of visceral fat macrophages independently by multivariate analysis. These results suggest that visceral fat inflammation is not involved in systemic inflammation of COPD, but is associated with lower lung volume.
我们在腹部手术期间收集内脏脂肪组织(n=120),主要用于早期腹部恶性肿瘤,并研究炎症细胞,包括巨噬细胞和细胞因子。与非吸烟者或健康吸烟者相比,具有阻塞性呼吸障碍和吸烟史的COPD组的巨噬细胞数量没有显著增加,巨噬细胞是脂肪组织炎症的标志物。此外,高血清CRP的COPD组的内脏脂肪巨噬细胞倾向于高于低CRP组,但未达到显著性。在整个研究中,通过多变量分析,BMI和%VC均与内脏脂肪巨噬细胞的数量独立地显著相关。这些结果表明,内脏脂肪炎症不参与COPD的全身性炎症,但与肺容量降低有关。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A novel treatment strategy targeting shugoshin 1 in hematological malignancies.
- DOI:10.1016/j.leukres.2012.10.002
- 发表时间:2013
- 期刊:
- 影响因子:2.7
- 作者:Jing Yang;T. Ikezoe;C. Nishioka;A. Yokoyama
- 通讯作者:Jing Yang;T. Ikezoe;C. Nishioka;A. Yokoyama
Assessment of como rbidites in COPD
COPD 合并症的评估
- DOI:
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:S Kawase ;M Takaoka;S Miyamoto ,H Ohnishi ;T Kubota,T Namikawa,K Hana zaki ;A Yokoyama.;Akihito Yokoyama.
- 通讯作者:Akihito Yokoyama.
Effect of Mustard Gas Exposure on Incidence of Lung Cancer: A Longitudinal Study
- DOI:10.1093/aje/kwq426
- 发表时间:2011-03-15
- 期刊:
- 影响因子:5
- 作者:Doi, Mihoko;Hattori, Noboru;Kohno, Nobuoki
- 通讯作者:Kohno, Nobuoki
Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids
- DOI:10.1016/j.jaci.2013.04.050
- 发表时间:2013-08-01
- 期刊:
- 影响因子:14.2
- 作者:Kanemitsu, Yoshihiro;Matsumoto, Hisako;Mishima, Michiaki
- 通讯作者:Mishima, Michiaki
Low Lung Volume Is Associated W ith Adipose Tissue Inflammation
肺容量低与脂肪组织炎症有关
- DOI:
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Kawase S;Miyamoto S;Ohnishi H;Kub ota T;Namikawa T;Hanazaki;Yokoyam a A.
- 通讯作者:Yokoyam a A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOKOYAMA AKIHITO其他文献
YOKOYAMA AKIHITO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOKOYAMA AKIHITO', 18)}}的其他基金
Clinical application and expression mechanisms for KL-6/MUC1 having a selectin ligand
具有选择素配体的KL-6/MUC1的临床应用和表达机制
- 批准号:
23390222 - 财政年份:2011
- 资助金额:
$ 2.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
$ 2.41万 - 项目类别:
Studentship
HAS2異常に伴う全身併存症合併炎症性肺疾患患者の表現型解明と臨床応用
伴有 HAS2 异常的全身合并症的炎症性肺病患者的表型阐明和临床应用
- 批准号:
24K11310 - 财政年份:2024
- 资助金额:
$ 2.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
乾癬併存症におけるCaveolin-1を介した病態的関与と発現制御
Caveolin-1 介导的银屑病合并症的病理参与和表达调控
- 批准号:
23K07789 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection
与 HIV 感染相关的肠道菌群失调和心血管合并症的多组学特征
- 批准号:
10762411 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Addressing Dental and Psychiatric Comorbidities: Screening and Referrals of HIV/AIDS Patients
解决牙科和精神合并症:艾滋病毒/艾滋病患者的筛查和转诊
- 批准号:
10671164 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Effect of stage at diagnosis, treatment, and physical comorbidities on mortality following cancer diagnosis among people with non-affective psychotic disorders: A causal mediation analysis
诊断、治疗和身体合并症的分期对非情感性精神障碍患者癌症诊断后死亡率的影响:因果中介分析
- 批准号:
495238 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Understanding cancer and comorbidities among American Indian and Alaska Native people
了解美洲印第安人和阿拉斯加原住民的癌症和合并症
- 批准号:
10722119 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Building Research Capacity to Study Periodontitis and Associated Systemic Comorbidities in the Caribbean
建设加勒比地区牙周炎及相关系统合并症的研究能力
- 批准号:
10664397 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Mechanisms of human appendicular and cardiovascular comorbidities: An analysis of heterogeneity and lineage trajectories of the lateral plate mesoderm
人类四肢和心血管合并症的机制:侧板中胚层的异质性和谱系轨迹分析
- 批准号:
10642590 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Defining a Stage-Based Framework of Comorbidities among Children with Severe Neurologic Impairment
定义严重神经损伤儿童合并症的阶段性框架
- 批准号:
479359 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Operating Grants